Dobutamine

Catecholamine (predominantly β1-sympathomimetic, inotrope)

For healthcare professionals. This information does not replace clinical judgement in the individual case; the current summary of product characteristics and the guidelines cited are authoritative.

Medically reviewed: Dr. med. univ. Daniel Pehböck, DESA, 01.11.2026

Dobutamine (Catecholamine (predominantly β1-sympathomimetic, inotrope)) – indications: Low output / cardiogenic shock with hypoperfusion. Weight-based dosing in mg and ml in the app, with sources.

Indications

Low output / cardiogenic shock with hypoperfusion

Complete in the app

Weight-based doses in mg and ml, preparations, contraindications and notes – in the app, also offline.

Open in the app Pocket book

Used in

Acute coronary syndrome
Pulmonary embolism
Acute heart failure & hypertensive emergency

Sources and guidelines

McDonagh TA et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2021;42:3599–3726; 2023 Focused Update, Eur Heart J 2023;44:3627–3639.